MiR-221/222 promotes S-Phase entry and cellular migration in control of basal-like breast cancer

Molecules

Volumn 19, Issue 6, 2014, Pages 7122-7137

  Li, Yuan ^a   Liang, Chunli ^a   Ma, Haizhong ^a,b   Zhao, Qian ^a   Lu, Ying ^a   Xiang, Zhendong ^a   Li, Li ^a   Qin, Jie ^c   Chen, Yihan ^a   Cho, William C ^d   Pestell, Richard G ^e   Liang, Li ^b   Yu, Zuoren ^a  

^a TONGJI UNIVERSITY SCHOOL OF MEDICINE   (China)

^b LANZHOU UNIVERSITY   (China)

^c FUDAN UNIVERSITY   (China)

^d QUEEN ELIZABETH HOSPITAL   (Hong Kong)

^e THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

Basal like breast cancer; Cell cycle; Migration; MiR 221; MiR 222

Indexed keywords

MICRORNA; MIRN221 MICRORNA, HUMAN; MIRN222 MICRORNA, HUMAN;

BREAST TUMOR; CELL CYCLE; CELL CYCLE S PHASE; CELL MOTION; FEMALE; GENE EXPRESSION REGULATION; GENETICS; HUMAN; METABOLISM; PHYSIOLOGY; TUMOR CELL LINE;

BREAST NEOPLASMS; CELL CYCLE; CELL LINE, TUMOR; CELL MOVEMENT; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MICRORNAS; S PHASE;

EID: 84903291430     PISSN: None     EISSN: 14203049     Source Type: Journal    
DOI: 10.3390/molecules19067122     Document Type: Article

References (36)

1. Chang, E.L.; Lo, S. Diagnosis and management of central nervous system metastases from breast cancer. Oncologist 2003, 8, 398-410.
2. Sanchez-Munoz, A.; Perez-Ruiz, E.; Ribelles, N.; Marquez, A.; Alba, E. Maintenance treatment in metastatic breast cancer. Expert Rev. Anticancer Ther. 2008, 8, 1907-1912.
3. Krek A.Grün D.Poy M.N.Wolf R.Rosenberg L.Epstein E.J.MacMenamin P.da Piedade, I.Gunsalus, K.C.Stoffel, M.et al. Combinatorial microRNA target predictions. Nat. Genet.2005. 37.495-500.
4. Yu, Z.; Baserga, R.; Chen, L.; Wang, C.; Lisanti, M.P.; Pestell, R.G. microRNA, cell cycle, and human breast cancer. Am. J. Pathol. 2010, 176, 1058-1064.
5. Cho, W.C. MicroRNAs : Potential biomarkers for cancer diagnosis, prognosis and targets for therapy. Int. J. Biochem. Cell. Biol. 2010, 42, 1273-1281.
6. Cho, W.C. Exploiting the therapeutic potential of microRNAs in human cancer. Expert Opin. Ther. Targets 2012, 16, 345-350.
7. Yu, Z.; Pestell, R.G. Small non-coding RNAs govern mammary gland tumorigenesis. J Mammary Gland Biol. Neoplasi. 2012, 17, 59-64.
8. Yu, Z.; Wang, L.; Wang, C.; Ju, X.; Wang, M.; Chen, K.; Loro, E.; Li, Z.; Zhang, Y.; Wu, K.; et al. Cyclin D1 induction of dicer governs microRNA processing and expression in breast cancer . Nat. Commun. 2013, 4, 2812.
9. Zhang, L.; Huang, J.; Yang, N.; Greshock, J.; Megraw, M.S.; Giannakakis, A.; Liang, S.; Naylor, T.L.; Barchetti, A.; Ward, M.R.; et al. mi croRNAs exhibit high frequency genomic alterations in human cancer. Proc. Natl. Acad. Sci. USA 2006, 103, 9136-9141.
10. Iorio, M.V.; Ferracin M.; Liu C.G.; Veronese A.; Spizzo R.; Sabbioni S.; Magri E.; Pedriali M.; Fabbri M.; Campiglio M.; et al. MicroRNA gene expression deregulation in human breast cancer. Cancer Res. 2005, 65, 7065-7070.
11. Frankel, L.B.; Christoffersen, N .R.; Jacobsen, A.; Lindow, M.; Krogh, A.; Lund, A.H. Programmed cell death 4 (PDCD4) is an important functional target of the microRNA miR-21 in breast cancer cells. J. Biol. Chem. 2008, 283, 1026-1033.
12. Mertens-Talcott, S.U.; Chintharlapalli, S.; Li, X.; Safe, S. The oncogenic microRNA-27a targets genes that regulate specificity protein transcription factors and the G2-M checkpoint in MDA-MB-231 breast cancer cells. Cancer Res. 2007, 67, 11001-11011.
13. Yu, Z.; Wang, C.; Wang, M.; Li, Z.; Casimiro, M.C.; Liu, M.; Wu, K.; Whittle, J.; Ju, X.; Hyslop, T.; et al. A cyclin D1/microRNA 17/20 reg ulatory feedback loop in control of breast cancer cell proliferation. J. Cell Biol. 2008, 182, 509-517.
14. Shan, S.W.; Lee, D.Y.; Deng, Z.; Shatseva, T.; Jeyapalan, Z.; Du, W.W.; Zhang, Y .; Xuan, J.W.; Yee, S.P.; Siragam, V.; et al. MicroRNA MiR-17 retards tissue growth and represses fibronectin expression. Natl. Cell Biol. 2009, 11, 1031-1038.
15. Gregory, P.A.; Bert, A.G.; Paterson, E.L.; Barry, S.C.; Tsykin, A.; Farshid, G.; Vadas, M.A.; Khew-Goodall, Y.; Goodall, G.J. The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1. Nat. Cell Biol. 2008, 10, 593-601.
16. Tavazoie, S.F.; Alarcó n, C.; Oskarsson, T.; Padua, D.; Wang, Q.; Bos, P.D.; Gerald, W.L.; Massagué, J. Endogenous human microRNAs that suppress breast cancer metasta sis. Nature 2008, 451, 147-152.
17. Yu, F.; Yao, H.; Zhu, P.; Zhang, X.; Pan, Q.; Gong, C.; Huang, Y.; Hu, X.; Su, F.; Lieberman, J.; et al. let-7 Regulates self renewal a nd tumorigenicity of breast cancer cells. Cell 2007, 131, 1109-1123.
18. Richardson, A.L.; Wang, Z.C.; de Nicolo, A.; Lu, X.; Brown, M.; Miron, A.; Liao, X.; Iglehart, J.D.; Livingston, D.M.; Ganesan, S. X chromosomal abnormalities in basal-like human breast cancer. Cancer Cell 2006, 9, 121-132.
19. Li, Y.; Liu, M,; Zhang, Y.; Han, C.; You, J.; Yang, J.; Cao, C.; Jiao, S. Effects of ARHI on breast cancer cell biological behavior regulated by m icroRNA-221. Tumour Biol. 2013, 34, 3545-54.
20. Chen, W.X.; Hu, Q.; Qiu, M.T.; Zhong, S.L.; Xu, J.J.; Tang, J.H.; Zhao, J.H. miR-221/222: Promising biomarkers for breast cancer. Tumour Biol. 2013, 34, 1361-1370.
21. Zhao, L.; Sun, Y.; Hou, Y.; Peng, Q.; Wang, L.; Luo, H.; Tang, X.; Zeng, Z.; Liu, M. MiRNA expression analysis of cancer-associated fibroblasts and norma l fibroblasts in breast cancer. Int. J. Biochem. Cell Biol. 2012, 44, 2051-2059.
22. Zhao, R.; Wu, J.; Jia, W.; Gong, C.; Yu, F.; Ren, Z.; Chen, K.; He, J.; Su, F. Plasma miR-221 as a predictive biomarker for chemoresistance in breast cancer patients who previously received neoadjuvant chemotherapy. Onkologie 2011, 34, 675-680.
23. Shah, M.Y.; Calin, G.A. MicroRNAs miR-221 and miR-222: A new level of regulation in aggressive breast cancer. Genome Med. 2011, 3,56.
24. Nassirpour, R.; Mehta, P.P.; Baxi, S.M.; Yin, M.J. miR-221 promotes tumorigenesis in human triple negative breast cancer cells. PLoS One 2013, 8, e62170.
25. Guttilla I.K.Phoenix K.N.Hong X.Tirnauer J.S.Claffey K.P.White B.A. Prolonged mammosphere culture of MCF-7 cells induces an EMT and rep ression of the estrogen receptor by microRNAs. Breast Cancer Res. Treat.2012.132.75-85.
26. Stinson, S.; Lackner, M.R.; Adai, A.T.; Yu, N.; Kim, H.J.; O?Brien, C.; Spoerke, J.; Jhunjhun wala, S.; Boyd, Z.; Januario, T.; et al. miR-221/222 targeting of trichorhinophalangeal 1 (TRPS1) promotes epithelial-to-mesenchymal transition in breast cancer. Sci. Signal. 2011, 4, pt5.
27. Yu, Z.; Willmarth, N.E.; Zhou, J.; Katiyar, S.; Wang, M.; Liu, Y.; McCue, P.A.; Quong, A.A.; Lisanti, M.P.; Pestell, R.G. microRNA 17/20 inhibits cellular invasion and tumor metastasis in breast cancer by heterotypic signali ng. Proc. Natl. Acad. Sci. USA 2010, 107, 8231-8236.
28. Stinson, S.; Lackner, M.R.; Adai, A.T.; Yu, N.; Kim, H.J.; O?Brien, C.; Spoerke, J.; Jhunjhunwala, S.; Boyd, Z.; Januario, T .; et al. TRPS1 targeting by miR-221/222 promotes the epithelial-tomesenchymal transition in breast cancer. Sci. Signal. 2011, 4, ra41.
29. Volinia, S.; Galasso, M.; Sana, M.E.; Wise, T.F.; Palati ni, J.; Huebner, K.; Croce, C.M. Breast cancer signatures for invasiveness and prognosis defined by deep sequencing of microRNA. Proc. Natl. Acad. Sci. USA 2012, 109, 3024-3029.
30. Sutherland, K.D.; Lindeman, G.J.; Choong, D.Y.; Wittlin, S.; Brentzell, L.; Phillips, W.; Campbell, I.G.; Visvader, J.E. Differential hypermethylation of SOCS genes in ovarian and breast carcinomas. Oncogene 2004, 23, 7726 -7733.
31. Zou, L.; Ding, Z.; Roy, P. Profilin-1 overexpression inhibits proliferation of MDA-MB-231 breast cancer cells partly through p27kip1 upregulation. J. Cell Physiol. 2010, 223, 623-629. 32.
32. Slattery, M.L.; Lundgreen, A.; Kadlubar, S.A.; Bondurant, K.L.; Wolff, R.K. JAK/STAT/SOCSsignaling pathway and colon and rectal cancer. Mol. Carcinog. 2013, 52, 155-66.
33. Xie, T.X.; Wei, D.; Liu, M.; Gao, A.C.; Ali-Osman, F.; Sawaya, R.; Huang, S. Stat3 activation regulates the expression of matrix metalloproteinase-2 and tumor invasion and metastasis. Oncogene 2004, 23, 3550-3560.
34. Chiu, W.T.; Lee, H.T.; Huang, F.J.; Aldape, K.D.; Yao, J.; Steeg, P.S.; Chou, C.Y.; Lu, Z.; Xie, K.; Huang, S. Caveolin-1 upregulation mediates suppression of p rimary breast tumor growth and brain metastases by stat3 inhibition. Cancer Res. 2011, 71, 4932-4943.
35. Liu, M.; Casimiro, M.C.; Wang, C.; Shirley, L.A.; Jiao, X.; Katiyar, S.; Ju, X.; Li, Z.; Yu, Z.; Zhou, J.; et al. p21CIP1 attenuates Ras-and c-Myc-dependent breast tumor epithelial mesenchymal transition and cancer stem cell-like gene expression in vivo. Proc. Natl. Acad. Sci. USA 2009, 106, 19035-1903 9.
36. Jackson, R.J.; Adnane, J.; Coppola, D.; Cantor, A.; Sebti, S.M.; Pledger, W.J. Loss of the cell cycle inhibitors p21(Cip1) and p27(Kip1) enhances tumorigenesis in knockout mouse models. Oncogene 2002, 21, 8486-8497. Municipality Municipality